102例慢性HBV感染者病毒基因变异情况分析*

doi:10.3969/j.issn.1672-5069.2016.03.025

Abstract

Zhang Xiehua, Lin Aiqing, Hu Yiling, et al. Hepatitis B viral gene mutation in 102 patients with hepatitis B viral infection[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2016, 19(4): 480-481.

[1] Gandhe SS,Chadha MS,Walimbe AM,et al. Hepatitis B virus:prevalence of precore/core promoter mutants in different clinical categories of Indian patients. J Viral Hepat,2003,10（5）:367-82.
[2] 中华医学会肝病学分会和感染病学分会.慢性乙型肝炎防治指南（2010年版）. 实用肝脏病杂志,2011,14（2）：81-89.
[3] Schaefer S. Hepatitis B virus taxonomy and hepatitis B virusgenotypes .World J Gastroenterol,2007,13（1）:14-21.
[4] Zhang Q,Cao G. Genotypes,mutations,and viral load of hepatitis B virus and the risk of hepatocellular carcinoma:HBV properties and hepatocarcinogenesis. Hepat Mon,2011,11（2）:86-91.
[5] 罗昊翔,申元英. 乙型肝炎病毒基因变异与血清e 抗原阴性的关系. 胃肠病学和肝病学杂志,2010,19（10）:962-964.
[6] 周建良,吴诗品. 拉米夫定治疗乙型肝炎病毒 B、C 基因型疗效比较. 中华肝脏病杂志,2004,12（8）:489-490.
[7] 方芳,冯钢. 慢性乙型肝炎患者乙肝病毒B、C基因型和阿德福韦酯耐药基因的相关性. 皖南医学院学报,2012,31（4）:291-294.
[8] 杨凡,李汛,龚作炯,等. HBeAg 阴性与阳性慢性乙型肝炎患者临床和病毒学特点分析. 中西医结合肝病杂志,2012,22（1）:15-16.
[9] 荣海燕,张朝霞.乙型肝炎病毒耐药突变与HBV-DNA量和HBeAg之间的相关性研究.实用医学杂志,2013,29（3）:404-406.
[10] 潘晓红. 500例乙型肝炎患者血清学检测与HBV-DNA检测相关性分析. 当代医学,2011,17（29）：1120.
[11] 张勇杨,王爱平. 乙型病毒基因型及基因变异与原发性肝癌的相关性. 江苏医药,2011,37（11）:1279-1281.
[12] Tan Y,Ding K,Su J,et al. The naturally occurring YMDD mutation among patients chronically infected HBV and un-treated with lamivudine：a systematic review and Meta analysis. PLoS One,2012,7（3）：32-39.
[13] 马莉,张蔚,许刚柱,等. 乙型肝炎病毒相关性肝癌患者癌组织中HBx 和 CEACAM1的表达及其意义. 吉林大学学报,2012,38（4）:770-774.

[1]	chronic hepatitis B Zhu Lingyun, Zhang Maohai Cui Shasha, et al.. Serum IL-12 and IL-18 levels as well as peripheral blood mononuclear cell FOXp3 in patients with [J]. Journal of Practical Hepatology, 2019, 22(6): 816-819.
[2]	Shi Yingying, Wang Yuanxi.. Impact of combination telbivudine and adefovir dipivoxil on renal functions in the treatment of patients with chronic hepatitis B [J]. Journal of Practical Hepatology, 2019, 22(6): 820-823.
[3]	Min Feng, Huang Wenqi, Wu Weibing, et al.. Implications of serum adipocytokine levels in patients with chronic hepatitis B [J]. Journal of Practical Hepatology, 2019, 22(6): 824-827.
[4]	patients with chronic hepatitis B Zhang Yingming, Shen Shuang, Tian Fei, et al.. Prediction of response to peginterferon alfa-2a by blood IFNL4 and IL-28B gene polymorphisms in [J]. Journal of Practical Hepatology, 2019, 22(6): 828-831.
[5]	chronic hepatitis B virus carriers Wu Haiyi, Chen Jianxin.. Diagnostic efficacy of four non-invasive diagnostic models in evaluating significant liver fibrosis in [J]. Journal of Practical Hepatology, 2019, 22(6): 832-835.
[6]	Ma Liying, Shen Lijuan.. Efficacy and safety of tenofovir in the treatment of pregnant women with high HBV DNA loads [J]. Journal of Practical Hepatology, 2019, 22(6): 836-839.
[7]	Li Chuanjie, Xu Jing, Wang Liangliang, et al.. Changes of serum HBsAg levels in patients with chronic hepatitis B receiving entecavir treatment [J]. Journal of Practical Hepatology, 2019, 22(6): 928-929.
[8]	Du Keye, Yang Dongliang, Liu Jia. Regulatory T cells in hepatitis B [J]. Journal of Practical Hepatology, 2019, 22(5): 613-616.
[9]	Liao Guichan, Peng Jie, Zhang Xiaoyong. Roles of hepatocytes in intrinsic innate immunity in control of hepatits B virus infection [J]. Journal of Practical Hepatology, 2019, 22(5): 617-619.
[10]	Zhao Xieshan, Wu Chunrong, Wang Chunfeng, et al. Preliminary study on the efficacy of combination of tenofovir and Anluo Huaxian pill in the treatment of patients with HBeAg-negative chronic hepatitis B [J]. Journal of Practical Hepatology, 2019, 22(5): 644-647.
[11]	Tu Jiexia, Wang An’na, Liao Ruoxi. Comparative study of interferon alpha -2b and peginterferon alpha -2a in the treatment of patients with chronic hepatitis B [J]. Journal of Practical Hepatology, 2019, 22(5): 648-651.
[12]	Gao Wei, Hou Yong. Diagnostic efficacy of hepatic fibrosis by liver stiffness measurement in patients with chronic hepatitis B [J]. Journal of Practical Hepatology, 2019, 22(5): 652-655.
[13]	Zhu Yucheng, Yan Jiawei, Sun Jingkun, et al. Serum diamine oxidase level in patients with hepatitis B-induced acute-on-chronic liver failure [J]. Journal of Practical Hepatology, 2019, 22(5): 672-675.
[14]	Zhang Mei, Shi Xiuying, Li Linjuan, et al. Hepatic expression of interferon inducible protein -10 in patients with hepatitis B liver cirrhosis and hepatogenic diabetes mellitus [J]. Journal of Practical Hepatology, 2019, 22(5): 688-691.
[15]	Bai Yichun, Deng Jihong, Mei Xiaoping. Efficacy of peginterferon alfa-2b treatment and affecting response factors in patients with chronic hepatitis B [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 490-493.

Hepatitis B viral gene mutation in 102 patients with hepatitis B viral infection

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments